| Ident. | Authors (with country if any) | Title |
|---|
| 000012 (2020) |
Seoyoung C. Kim [États-Unis] ; Sebastian Schneeweiss [États-Unis] | When Randomized Clinical Trials and Real-World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety. |
| 000298 (2020) |
Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon] | Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. |
| 000382 (2020) |
Jacqueline M. Tarrant [États-Unis] ; René Galien [France] ; Wanying Li [États-Unis] ; Lovely Goyal [États-Unis] ; Yang Pan [États-Unis] ; Rachael Hawtin [États-Unis] ; Wangshu Zhang [États-Unis] ; Annegret Van Der Aa [Belgique] ; Peter C. Taylor [Royaume-Uni] | Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials |
| 000407 (2020) |
Ambrish Singh [Australie] ; Debashish Danda [Inde] ; Salman Hussain [Inde] ; Abul Kalam Najmi [Inde] ; Ashish Mathew [Inde] ; Ruchika Goel [Inde] ; Shaheen E. Lakhan [États-Unis] ; Belzik Tajudheen [Inde] ; Benny Antony [Australie] | Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials. |
| 000488 (2020) |
Jennie H. Best [États-Unis] ; Steven C. Vlad [États-Unis] ; Jinglan Pei [États-Unis] | Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis |
| 000521 (2020) |
Jon T. Giles [États-Unis] ; Naveed Sattar [Royaume-Uni] ; Sherine Gabriel [États-Unis] ; Paul M. Ridker [États-Unis] ; Steffen Gay [Suisse] ; Charles Warne [Royaume-Uni] ; David Musselman [États-Unis] ; Laura Brockwell [Royaume-Uni] ; Emma Shittu [Royaume-Uni] ; Micki Klearman [États-Unis] ; Thomas R. Fleming [États-Unis] | Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial. |
| 000616 (2019-06-12) |
Kedra Joanna [France] ; Philippe Dieudé [France] ; Hubert Marotte [États-Unis] ; Alexandre Lafourcade [France] ; Emilie Ducourau [France] ; Thierry Schaeverbeke [France] ; Aleth Perdriger [France] ; Martin Soubrier [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Emmanuelle Dernis [France] ; Valérie Royant [France] ; Jean-Hugues Salmon [France] ; Thao Pham [France] ; Jacques-Eric Gottenberg [France] ; Edouard Pertuiset [France] ; Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Philippe Gaudin [France] ; Gregoire Cormier [France] ; Philippe Goupille [France] ; Xavier Mariette [France] ; Francis Berenbaum [France] ; Didier Alcaix [France] ; Sid Ahmed Rouidi [France] ; Jean-Marie Berthelot [France] ; Agnès Monnier [France] ; Christine Piroth [France] ; Frederic Liote [France] ; Vincent Goeb [France] ; Cécile Gaujoux-Viala [France] ; Isabelle Chary Valckenaere [France] ; David Hajage [France] ; Florence Tubach [France] ; Bruno Fautrel [France] | Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission |
| 000925 (2019) |
Raimon Sanmarti [Espagne] ; Douglas J. Veale [Irlande (pays)] ; Emilio Martin-Mola [Espagne] ; Alejandro Escudero-Contreras [Espagne] ; Carlos González [Espagne] ; Liliana Ercole [Espagne] ; Rocío Alonso [Espagne] ; João E. Fonseca [Portugal] | Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial. |
| 000985 (2019) |
Vincent Chow ; Myungshin Oh ; Melissa A. Gessner ; Gary Fanjiang | Pharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single‐Blind, Single‐Dose, Parallel‐Group Study in Healthy Subjects |
| 000C57 (2019) |
John H. Stone ; Katie Tuckwell ; Sophie Dimonaco ; Micki Klearman ; Martin Aringer ; Daniel Blockmans ; Elisabeth Brouwer ; Maria C. Cid ; Bhaskar Dasgupta ; Juergen Rech ; Carlo Salvarani ; Hendrik Schulze-Koops ; Georg Schett ; Robert Spiera ; Sebastian H. Unizony ; Neil Collinson | Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab |
| 000C87 (2019) |
Anne-Sophie Wedell-Neergaard [Danemark] ; Louise Lang Lehrskov [Danemark] ; Regitse H Jgaard Christensen [Danemark] ; Grit Elster Legaard [Danemark] ; Emma Dorph [Danemark] ; Monica Korsager Larsen [Danemark] ; Natja Launbo [Danemark] ; Sabrina Ravn Fagerlind [Danemark] ; Sidsel Kofoed Seide [Danemark] ; Stine Nymand [Danemark] ; Maria Ball [Danemark] ; Nicole Vinum [Danemark] ; Camilla Noerfelt Dahl [Danemark] ; Marie Henneberg [Danemark] ; Mathias Ried-Larsen [Danemark] ; Janus Damm Nybing [Danemark] ; Robin Christensen [Danemark] ; Jaya Birgitte Rosenmeier [Danemark] ; Kristian Karstoft [Danemark] ; Bente Klarlund Pedersen [Danemark] ; Helga Ellingsgaard [Danemark] ; Rikke Krogh-Madsen [Danemark] | Exercise-Induced Changes in Visceral Adipose Tissue Mass Are Regulated by IL-6 Signaling: A Randomized Controlled Trial. |
| 000D29 (2019) |
Louise Lang Lehrskov [Danemark] ; Regitse H Jgaard Christensen [Danemark] ; Anne-Sophie Wedell-Neergaard [Danemark] ; Grit Elster Legaard [Danemark] ; Emma Dorph [Danemark] ; Monica Korsager Larsen [Danemark] ; Marie Henneberg [Danemark] ; Natja Launbo [Danemark] ; Sabrina Ravn Fagerlind [Danemark] ; Sidsel Kofoed Seide [Danemark] ; Stine Nymand [Danemark] ; Maria Ball [Danemark] ; Nicole Vinum [Danemark] ; Camilla Dahl [Danemark] ; Nicolai Jacob Wewer Albrechtsen [Danemark] ; Jens Juul Holst [Danemark] ; Mathias Ried-Larsen [Danemark] ; Jaya Birgitte Rosenmeier [Danemark] ; Rikke Krogh-Madsen [Danemark] ; Kristian Karstoft [Danemark] ; Bente Klarlund Pedersen [Danemark] ; Helga Ellingsgaard [Danemark] | Effects of Exercise Training and IL-6 Receptor Blockade on Gastric Emptying and GLP-1 Secretion in Obese Humans: Secondary Analyses From a Double Blind Randomized Clinical Trial |
| 000D39 (2019) |
Wenhui Xie ; Shiyu Xiao ; Yanrong Huang ; Xiaoying Sun ; Zhuoli Zhang | Effect of tofacitinib on cardiovascular events and all-cause
mortality in patients with immune-mediated inflammatory diseases: a systematic
review and meta-analysis of randomized controlled trials |
| 000D75 (2019) |
Niels Graudal [Danemark] ; Benjamin Skov Kaas-Hansen [Danemark] ; Louise Guski [Danemark] ; Thorbj Rn Hubeck-Graudal [Danemark] ; Nicky J. Welton [Royaume-Uni] ; Gesche Jürgens [Danemark] | Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis—A Network Meta-Analysis of 36 Randomized Controlled Trials |
| 000E78 (2019) |
Farsad Eskandary [Autriche] ; Michael Dürr [Allemagne] ; Klemens Budde [Allemagne] ; Konstantin Doberer [Autriche] ; Roman Reindl-Schwaighofer [Autriche] ; Johannes Waiser [Allemagne] ; Markus Wahrmann [Autriche] ; Heinz Regele [Autriche] ; Andreas Spittler [Autriche] ; Nils Lachmann [Allemagne] ; Christa Firbas [Autriche] ; Jakob Mühlbacher [Autriche] ; Gregor Bond [Autriche] ; Philipp F. Halloran ; Edward Chong [Canada] ; Bernd Jilma [Autriche] ; Georg A. Böhmig [Autriche] | Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial |
| 001015 (2019) |
Ulrika Bergsten ; Katarina Almehed ; Amir Baigi ; Lennart T. H. Jacobsson | A randomized study comparing regular care with a nurse‐led clinic based on tight disease activity control and person‐centred care in patients with rheumatoid arthritis with moderate/high disease activity: A 6‐month evaluation |
| 001168 (2018) |
Christopher J. Edwards [Royaume-Uni] ; Andrew J K. Östör [Australie] ; Barbara Naisbett-Groet ; Patrick Kiely [Royaume-Uni] | Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial. |
| 001181 (2018) |
Joel M. Kremer [États-Unis] ; William Rigby [États-Unis] ; Nora G. Singer [États-Unis] ; Christine Birchwood [États-Unis] ; Darcy Gill [États-Unis] ; William Reiss [États-Unis] ; Jinglan Pei [États-Unis] ; Margaret Michalska [États-Unis] | Sustained Response Following Discontinuation of Methotrexate in Patients With Rheumatoid Arthritis Treated With Subcutaneous Tocilizumab: Results From a Randomized, Controlled Trial. |
| 001221 (2018) |
Gablu Kilcher [Suisse] ; Noemi Hummel [Suisse] ; Eva M. Didden [Suisse] ; Matthias Egger [Suisse] ; Stephan Reichenbach [Suisse] | Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries. |
| 001263 (2018) |
Vibeke Strand [États-Unis] ; Laure Gossec [France] ; Clare W. J. Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Matthew Reaney [Royaume-Uni] ; Sophie Guillonneau [France] ; Toshio Kimura [États-Unis] ; Janet Van Adelsberg [États-Unis] ; Yong Lin [États-Unis] ; Erin K. Mangan [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Gerd R. Burmester [Allemagne] | Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis |
| 001296 (2018) |
Stephan Reichenbach [Suisse] ; Sabine Adler [Suisse] ; Harald Bonel [Suisse] ; Jennifer L. Cullmann [Suisse] ; Stefan Kuchen [Suisse] ; Lukas Bütikofer [Suisse] ; Michael Seitz [Suisse] ; Peter M. Villiger [Suisse] | Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritis. |
